Welcome!
China Resources Pharmaceutical Commercial Group Co (CRPCG)
Deals, joint ventures & alliances
iX Biopharma signs agreement with China Resources Pharmaceutical Commercial Group to distribute Wafesil in China
The licensing agreement runs for an initial term of 10 years.
September 30, 2021
Broker's Calls
PhillipCapital 'remains confident' in iX Biopharma’s growth prospects upon China agreement
PhillipCapital has kept its "buy" recommendation with the same target price of 44.5 cents.
April 08, 2021